Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 233 shares at $9.00 ($2K) on 2018-05-09, disclosed to the SEC on 2018-05-10.
Scheduled sale ($2k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |